Rahoto kan sakamakon kudi na kamfanin Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Regeneron Pharmaceuticals, Inc. buga rahotanni na kudi?
Regeneron Pharmaceuticals, Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a Yuro a yau
Regeneron Pharmaceuticals, Inc. kudin shiga da kudin shiga na yanzu don sabon rahotonni. Hanyoyin shiga yanar gizo Regeneron Pharmaceuticals, Inc. yanzu 2 528 700 000 €. Ana ɗaukar bayanai game da kudaden shiga daga hanyoyin buɗe. Thearfafawar Regeneron Pharmaceuticals, Inc. samun kudin shiga ya ragu ta hanyar -34 000 000 €. Assessmentididdigar yawan kuɗaɗen Regeneron Pharmaceuticals, Inc. An samu kuɗin shiga ƙasa idan aka kwatanta da rahoton da ya gabata. Regeneron Pharmaceuticals, Inc. ginshiƙi akan rahoton hada-hadar kudi ta yanar gizo. Jadawalin hada-hadar kudi na Regeneron Pharmaceuticals, Inc. ya kunshi jigogi uku na manyan alamu na hada-hadar kamfanin: jimillar kadarori, kudaden shiga, sahihan kudaden shiga. Darajar "jimlar kudaden shiga ta Regeneron Pharmaceuticals, Inc." akan wannan hoton an yiwa alama mai launin shuɗi.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Zamanin Regeneron Pharmaceuticals, Inc. rahotannin kudi: 30/06/2020, 31/12/2020, 31/03/2021. Kwanan bayanan bayanan kuɗi ana kiyaye su ta hanyar doka da kuma bayanan kuɗi. Rahoton sabon kudi na Regeneron Pharmaceuticals, Inc. yana nan akan layi akan irin wannan ranar - 31/03/2021. Babban riba Regeneron Pharmaceuticals, Inc. shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Regeneron Pharmaceuticals, Inc. ne 1 477 800 000 €
Dates na kudi rahotanni Regeneron Pharmaceuticals, Inc.
Ribar kuɗi Regeneron Pharmaceuticals, Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Regeneron Pharmaceuticals, Inc. ne 1 115 200 000 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
1 374 967 287 €
1 059 370 519 €
1 242 476 191 €
888 081 117.50 €
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
977 773 123.50 €
1 021 223 504 €
891 895 819 €
928 088 962.50 €
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
2 352 740 410.50 €
2 080 594 023 €
2 134 372 010 €
1 816 170 080 €
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
1 035 272 770.50 €
823 696 399.50 €
979 820 036.50 €
610 724 406 €
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
1 037 598 808 €
1 069 232 918 €
783 502 471.50 €
834 861 379.50 €
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
-
-
-
-
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
1 317 467 640 €
1 256 897 623.50 €
1 154 551 973.50 €
1 205 445 674 €
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
9 355 415 866.50 €
9 098 621 326.50 €
8 464 543 504 €
7 313 247 983 €
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
16 535 521 463 €
15 968 991 769.50 €
14 964 794 860 €
13 424 678 910.50 €
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
1 337 843 728.50 €
2 041 051 385.50 €
1 463 542 795 €
1 853 572 763 €
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
11 143 580 455 €
10 258 104 499.50 €
9 420 917 082.50 €
8 427 140 821 €
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
Rahoton kudi na baya-bayan nan game da kudin shiga na Regeneron Pharmaceuticals, Inc. shine ranar 31/03/2021. A cewar sabon rahoto game da sakamakon kudi na Regeneron Pharmaceuticals, Inc., yawan kudaden da Regeneron Pharmaceuticals, Inc. ya samu ya kai 2 352 740 410.50 Yuro kuma ya canza zuwa 0% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Regeneron Pharmaceuticals, Inc. a cikin kwata na karshe shine 1 037 598 808 €, karuwar riba ta karu da 0% idan aka kwatanta da bara.
Kudin hannun jari Regeneron Pharmaceuticals, Inc.
Kudin hannun jari Regeneron Pharmaceuticals, Inc.
Sharorin Regeneron Pharmaceuticals, Inc. a yau, farashin kayayyaki RGO.F yana da layi yanzu.
Rahoto kan sakamakon kudi na kamfanin Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024.
